photo of

Details

Role Clinical Geneticist
Group Clinical Services
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of...
Professor Martin Delatycki is a co-director of the Bruce Lefroy Centre at the Murdoch Children's Research Institute (MCRI) and a clinical geneticist at the Victorian Clinical Genetics Services (VCGS). Martin studied medicine at the University of Melbourne and trained in paediatrics at The Royal Children’s Hospital (RCH).

Martin subsequently trained in Clinical Genetics at VCGS and then obtained his PhD for work on Friedreich ataxia through the MCRI. His research and clinical interests are neurogenetics and community genetics. Martin has over 250 publications and has obtained over $5 million in research funding.

Top Publications

  • Park, HA, Neumeyer, S, Michailidou, K, Bolla, MK, Wang, Q, Dennis, J, Ahearn, TU, Andrulis, IL, Anton-Culver, H, Antonenkova, NN, et al. Mendelian randomisation study of smoking exposure in relation to breast cancer risk.. Br J Cancer 125(8) : 1135 -1145 2021
    view publication
  • Murali, K, Dwarte, TM, Nikfarjam, M, Tucker, KM, Vaughan, RB, Efthymiou, M, Collins, A, Spigelman, AD, Salmon, L, Johns, AL, et al. Correction to: Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.. Hered Cancer Clin Pract 19(1) : 37 2021
    view publication
  • Ravenscroft, G, Clayton, JS, Faiz, F, Sivadorai, P, Milnes, D, Cincotta, R, Moon, P, Kamien, B, Edwards, M, Delatycki, M, et al. Neurogenetic fetal akinesia and arthrogryposis: genetics, expanding genotype-phenotypes and functional genomics.. J Med Genet 58(9) : 609 -618 2021
    view publication
  • Murali, K, Dwarte, TM, Nikfarjam, M, Tucker, KM, Vaughan, RB, Efthymiou, M, Collins, A, Spigelman, AD, Salmon, L, Johns, AL, et al. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.. Hered Cancer Clin Pract 19(1) : 33 2021
    view publication
  • Forbes Shepherd, R, Keogh, LA, Werner-Lin, A, Delatycki, MB, Forrest, LE. Benefits and burdens of risk management for young people with inherited cancer: A focus on Li-Fraumeni syndrome.. Aust J Gen Pract 50(8) : 538 -544 2021
    view publication